Search Results - "Korenblat, P"

The role of antileukotrienes in the treatment of asthma by Korenblat, P E

“…This article reviews the literature on the role of antileukotrienes (anti-LTs), specifically montelukast, zafirlukast, and zileuton, in the treatment of…”
Get more information

Phase 2/3 Study of the Novel Vaccine Amb a 1 Immunostimulatory Oligodeoxyribonucleotide Conjugate AIC in Ragweed-Allergic Adults by Busse, W., Gross, G., Korenblat, P., Nayak, N., Tarpay, M., Levitt, D.

Get full text

Omalizumab, an anti-IgE antibody, significantly reduces emergency visits in patients with severe persistent asthma: A pooled analysis by Korenblat, P., Meltzer, E., Busse, W., Hedgecock, S., Fox, H., Blogg, M.

“…The annualized rate of total emergency visits (hospital admissions, emergency room visits and unscheduled doctor visits) were pooled and rate ratios…”
Get full text

Omalizumab add-on therapy significantly reduces asthma exacerbations in patients with inadequately controlled severe persistent asthma despite GINA 2002 step 4 therapy: INNOVATE by Korenblat, P., Levy, R., Slavin, R., Hedgecock, S., Fox, H., Surrey, K.

“…Patients with inadequately controlled severe persistent asthma despite GINA 2002 step 4 therapy (high-dose inhaled corticosteroids [ICS] plus long-acting…”
Get full text

Effect of fluticasone propionate aqueous nasal spray versus oral prednisone on the hypothalamic-pituitary-adrenal axis by Vargas, Ramón, Dockhorn, Robert J., Findlay, Steven R., Korenblat, Phillip E., Field, Elizabeth A., Kral, Kenneth M.

“…Background: Fluticasone propionate is a glucocorticoid with negligible oral bioavailability and very low intranasal bioavailability that is used as an…”
Get full text

A retrospective study of epinephrine administration for anaphylaxis: how many doses are needed? by Korenblat, P, Lundie, M J, Dankner, R E, Day, J H

“…The precise amount of epinephrine needed to reverse severe symptomatology due to an anaphylactic reaction is unknown. We tried to determine how frequently more…”
Get more information

Effect of age on response to zafirlukast in patients with asthma in the Accolate Clinical Experience and Pharmacoepidemiology Trial (ACCEPT) by Korenblat, P E, Kemp, J P, Scherger, J E, Minkwitz, M C, Mezzanotte, W

“…The Accolate Clinical Experience and Pharmacoepidemiology Trial (ACCEPT), evaluated zafirlukast in a wide spectrum of patients from a variety of clinical…”
Get more information

Tracheobronchomalacia as a Co-Morbidity of Asthma and as an Alternate Diagnosis to Asthma by Korenblat, P.E, Bierhals, A.J, Senior, R.M

“…When asthma-like symptoms are not controlled by maximal therapy considering co-morbidities or alternative diagnoses is necessary…”
Get full text

Dose‐proportional pharmacokinetics of budesonide inhaled via Turbuhaler by KAISER, H, AARONSON, D, DOCKHORN, R, EDSBÄCKER, S, KORENBLAT, P, KÄLLEN, A

“…Aims The present pharmacokinetic study was undertaken to determine the dose proportionality of three different doses of budesonide—400 μg, 800 μg or 1600 μg…”
Get full text

Effect of omalizumab on healthcare utilization in patients with moderate to severe allergic asthma by Chipps, B., Kim, K., Korenblat, P., Deniz, Y., Zheng, B., Carroll, A.

Get full text

P069 EFFECT OF LEBRIKIZUMAB ON LUNG FUNCTION IN PATIENTS WITH SEVERE EOSINOPHILIC ASTHMA by Korenblat, P., Sher, E., Berman, G., Hanania, N., Fineman, S., Zitnik, R., Gopalan, R., Sun, L., Corren, J.

Get full text

Triamcinolone acetonide aqueous nasal spray in patients with seasonal ragweed allergic rhinitis: A placebo-controlled, double-blind study by Settipane, Guy, Korenblat, Philip E., Winder, John, Lumry, William, Murphree, Jean, Alderfer, Vivian B., Simpson, Brandon, Smith, Joseph A.

“…Because some patients may prefer aqueous nasal sprays and once-daily dosing for relief of seasonal allergic rhinitis symptoms, a new aqueous formulation of…”
Get full text

283 Cost efficacy of nedocromil sodium (NED) aerosol for asthma by Korenblat, P., Farrar, J.

Get full text

Colonic mucosal speckling detected by endoscopy: histopathologic differential diagnosis by Weinstock, Leonard B., Shatz, Burton A., Thyssen, Erik P., Ritter, Jon H., Korenblat, Phillip E., Deschryver, Katherine

Get full text

The Safety and Efficacy of Infliximab in Moderate to Severe Chronic Obstructive Pulmonary Disease by Rennard, Stephen I, Fogarty, Charles, Kelsen, Steven, Long, William, Ramsdell, Joe, Allison, James, Mahler, Donald, Saadeh, Constantine, Siler, Thomas, Snell, Phillip, Korenblat, Phillip, Smith, William, Kaye, Mitchell, Mandel, Michael, Andrews, Charles, Prabhu, Rachakonda, Donohue, James F, Watt, Rosemary, Lo, Kim Hung, Schlenker-Herceg, Rozsa, Barnathan, Elliot S, Murray, John, on behalf of COPD Investigators

“…Chronic obstructive pulmonary disease (COPD) is a progressive, smoking-related, inflammatory lung disease in which tumor necrosis factor-alpha is overexpressed…”
Get full text

Systemic mastocytosis presenting as osteoporosis: a clinical and histomorphometric study by Chines, A, Pacifici, R, Avioli, L V, Teitelbaum, S L, Korenblat, P E

“…Ten patients with systemic mastocytosis (SM) were evaluated for their metabolic bone disease (4 men and 6 women; mean +/- SD, 59 +/- 13 yr). All patients…”
Get more information

Daclizumab Improves Asthma Control in Patients with Moderate to Severe Persistent Asthma: A Randomized, Controlled Trial by Busse, William W, Israel, Elliot, Nelson, Harold S, Baker, James W, Charous, B. Lauren, Young, Donald Y, Vexler, Vladimir, Shames, Richard S, Daclizumab Asthma Study Group

“…Airway inflammation in asthma is associated with increased activated CD25(+) T cells, IL-2, and soluble IL-2 receptors (IL-2Rs). A randomized, double-blinded,…”
Get full text

Common variable immunodeficiency in a renal transplant patient with severe recurrent bacterial infection: a case report and review of the literature by Miller, B W, Brennan, D C, Korenblat, P E, Goss, J A, Flye, M W

“…The second reported case of common variable immunodeficiency (acquired agammaglobulinemia) after renal transplantation is presented. Agammaglobulinemia…”
Get more information

Systemic mastocytosis and osteoporosis by Chines, A, Pacifici, R, Avioli, L A, Korenblat, P E, Teitelbaum, S L

Get full text

D36 ALL TOGETHER NOW: COPD TREATMENT WITH LONG-ACTING BETA AGONISTS AND LONG-ACTING MUSCARINIC ANTAGONISTS: Glycopyrronium Twice Daily Improves Lung Function And Health Status And Is Well Tolerated In COPD Patients With Moderate-To-Severe Airflow Limitation: The Gem2 Study by Kerwin, E M, Siler, T M, Korenblat, P E, White, A C, Eckert, J H, Cha, E, Mota, F, Andrea, P D

Get full text